Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488027
Status:
COMPLETED
Last Update Posted:
2024-07-05
First Post:
2024-06-28
Brief Title:
DAO DEFICIENCY SCREENING AMONG PATIENTS with INSOMNIA SYMPTOMS
Sponsor:
AB Biotek
Organization:
AB Biotek
Study Overview
Official Title:
DAO DEFICIENCY SCREENING AMONG PATIENTS with INSOMNIA SYMPTOMS
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Insomnia is prevalent in the global population Diamino oxidase DAO is an enzyme that degrades histamine When there is not enough DAO enzyme activity in the body histamine accumulates and it can lead to symptoms in the nervous system among others In this study we wanted to study the prevalence of DAO deficiency in pacients with insomnia symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None